Meningococcal (vaccine)

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Infections, Meningococcal

Phase 2

Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years

CompletedNCT00196950

GlaxoSmithKlineInfections, Meningococcal

Start: 2003-09-30End: 2003-10-31Updated: 2016-09-07

Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

CompletedNCT00196963

GlaxoSmithKlineInfections, Meningococcal

Start: 2005-03-31End: 2005-07-31Updated: 2016-09-21